aspirin has been researched along with arginyl-glycyl-aspartyl-serine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beers, KN; Eckardt, A; Falotico, R; Ginsberg, MH; Offord, S; Press, JB; Sanfilippo, PJ; Tighe, J; Tomko, K; Urbanski, MJ | 1 |
| Liu, J; Peng, S; Wang, C; Zhao, M | 1 |
| Cui, G; Peng, S; Zhang, J; Zhao, M | 1 |
| Gui, L; Li, Z; Peng, S; Wang, X; Wang, Y; Wu, J; Zhang, X; Zhao, M; Zhao, S; Zheng, M | 1 |
| Chen, JH; Karlberg, KE; Sylvén, C | 1 |
| Bernat, A; Defreyn, G; Herbert, JM; Maffrand, JP; Mares, AM | 1 |
| Evanson, OA; Weiss, DJ; Wells, RE | 1 |
| Calzada, C; Lagarde, M; Vericel, E | 1 |
| Hirasawa, Y; Ito, K; Kato, Y; Kita, Y; Motoyama, Y; Nishio, M; Seki, J; Yamanaka, T | 1 |
| Fälker, K; Lange, D; Presek, P | 1 |
| Abdulrehman, AY; Jackson, EC; McNicol, A | 1 |
11 other study(ies) available for aspirin and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen-mediated platelet aggregation.
Topics: Fibrinogen; Flow Cytometry; Humans; Iodine Radioisotopes; Kinetics; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Thiazoles; Thrombin | 1995 |
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
Topics: Amino Acid Sequence; Nitrogen Oxides; Oligopeptides; Structure-Activity Relationship | 2003 |
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
Topics: Amino Acids, Acidic; Amino Acids, Basic; Animals; Cytoprotection; Electron Spin Resonance Spectroscopy; Fibrinolytic Agents; Free Radicals; Molecular Structure; Nitrogen Oxides; PC12 Cells; Peptides; Platelet Aggregation; Rats; Structure-Activity Relationship; Vasodilation | 2008 |
Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor.
Topics: Administration, Oral; Animals; Binding Sites; Blood Platelets; Drug Design; Microscopy, Atomic Force; Molecular Docking Simulation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Structure, Tertiary; Rats; Stereoisomerism; Thermodynamics; Thiazoles; Thrombosis | 2017 |
Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers.
Topics: Adult; Aspirin; Collagen; Dose-Response Relationship, Drug; Female; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Male; Middle Aged; Oligopeptides; Platelet Aggregation; Platelet Membrane Glycoproteins; Stimulation, Chemical | 1991 |
Effect of various antiplatelet agents on acute arterial thrombosis in the rat.
Topics: Acute Disease; Amino Acid Sequence; Animals; Aspirin; Carotid Artery Thrombosis; Clopidogrel; Electric Stimulation; Hirudin Therapy; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thiazoles; Thrombolytic Therapy; Thromboxane-A Synthase; Ticlopidine | 1993 |
Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
Topics: Animals; Arginine; Aspartic Acid; Aspirin; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; Glycine; Horses; Oligopeptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex | 1997 |
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Deferoxamine; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Hydrazines; Hydrogen Peroxide; Leukotrienes; Lipid Peroxides; Oligopeptides; Peroxides; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; tert-Butylhydroperoxide; Thromboxane B2; Vitamin E | 1997 |
In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Topics: Arginine; Aspirin; Benzamides; Dipeptides; Dose-Response Relationship, Drug; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Serine Endopeptidases; Sulfonamides; Thiazoles; Thiazolidines; Thrombin | 1999 |
P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Topics: Adenine; Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Aspirin; Blood Platelets; Collagen; Cyclic AMP; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epinephrine; Epoprostenol; Humans; Membrane Proteins; Oligopeptides; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; Thrombin; Time Factors; Tyrosine | 2005 |
Platelet activation by Streptococcus sanguinis is accompanied by MAP kinase phosphorylation.
Topics: Antigens, Human Platelet; Aspirin; Blood Platelets; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activation; Platelet Aggregation; Streptococcus sanguis | 2013 |